Earnings History Data for Avalo Therapeutics (AVTX) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Avalo Therapeutics
Avalo Therapeutics Inc. is a clinical-stage precision medicine company which discovers, develops and commercializes targeted therapeutics for patients with significant unmet clinical need in immunology, immuno-oncology and rare genetic diseases. Avalo Therapeutics Inc., formerly known as Cerecor, is based in WAYNE, Pa.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 07-11-2024 | PM | AVTX | Avalo Therapeutics | 14.00 | -2.83 | -1.19 | 0.00 | Avalo Therapeutics GAAP EPS of -$2.83, revenue of $0.25M [11/7/2024 9:34 AM] |
12.51 | -0.89 (-6.64%) |
0.0 | 0.0 (0.00%) |
3.95 - 34.46 | 15,107 | 60,000 | 0 | ||
| 12-08-2024 | PM | AVTX | Avalo Therapeutics | 12.00 | -14.07 | -6.70 | 0.00 | Avalo Therapeutics GAAP EPS of -$14.07 [8/12/2024 7:26 AM] |
9.89 | -0.79 (-7.40%) |
0.0 | 0.0 (0.00%) |
3.95 - 71.04 | 18,723 | 10,000 | 0 | ||
| 13-05-2024 | PM | AVTX | Avalo Therapeutics | 12.00 | -5.98 | -1.18 | 0.00 | Avalo Therapeutics reports Q1 results [5/13/2024 8:05 AM] |
10.74 | -0.11 (-1.01%) |
10.98 | 0.13 (1.20%) |
3.95 - 1,130.40 | 47,318 | 60,000 | 755 | ||
| 09-11-2023 | PM | AVTX | Avalo Therapeutics | 2.00 | -0.11 | -1.10 | 0.00 | Avalo Therapeutics GAAP EPS of -$0.11 beats by $0.99, revenue of $0.24M misses by $0.76M [11/9/2023 7:46 AM] |
0.0954 | -0.01 (-12.48%) |
0.11 | 0.0 (1.28%) |
0.08 - 6.60 | 31,475,864 | 34,220,000 | 6,230,328 | ||
| 07-11-2022 | PM | AVTX | Avalo Therapeutics | 65.00 | 0.34 | -1.03 | 0.00 | Avalo Therapeutics GAAP EPS of $0.34 beats by $1.04, revenue of $14.95M [11/7/2022 8:22 AM] |
6.70 | -0.08 (-1.18%) |
6.78 | 0.0 (0.00%) |
2.42 - 28.68 | 34,838 | 20,000 | 107 | ||
| 04-08-2022 | PM | AVTX | Avalo Therapeutics | 33.00 | -1.38 | -1.80 | 0.00 | Avalo Therapeutics GAAP EPS of -$1.38 beats by $0.37, revenue of $1.03M beats by $0.29M [8/4/2022 9:01 AM] |
4.01 | 0.36 (9.86%) |
3.92 | -0.40 (-9.26%) |
2.42 - 38.88 | 141,876 | 40,000 | 51,552 | ||
| 05-05-2022 | PM | AVTX | Avalo Therapeutics | 48.00 | -0.20 | -0.14 | 0.00 | Avalo Therapeutics GAAP EPS of -$0.20 misses by $0.08, revenue of $1.17M beats by $0.65M [5/5/2022 8:55 AM] |
0.3277 | -0.07 (-16.81%) |
0.40 | 0.01 (1.55%) |
0.31 - 3.70 | 1,091,035 | 470,000 | 905 | ||
| 09-11-2021 | AH | AVTX | Avalo Therapeutics, Inc. | 266.19 | -0.17 | -0.19 | -0.16 | Avalo Therapeutics EPS beats by $0.01, beats on revenue [11/9/2021 4:54 PM] |
2.28 | -0.04 (-1.72%) |
2.21 | -0.11 (-4.74%) |
1.99 - 4.50 | 243,289 | 330,000 | 507 | ||